Correction: PAK4 inhibition enhances the efficacy of PD-1 blockade immunotherapy

1

A correction to the Nature Cancer article was published online on December 9, 2019.
2

The original Figure 5 legend and source data file did not state that the 16 mice per group in Figure 5a were pooled across three independent experiments.
3

Figure 5d showed one experiment with 6 mice each in the PAK4 KO isotype and PAK4 KO anti-PD-1 groups.
4

Figure 5d also included 5 mice in the PAK4 KO anti-PD-1 anti-CD8 group.
5

The Figure 5 legend and source data file were amended, and the correction was incorporated into the HTML and PDF versions.

Nature Cancer

by Gabriel Abril-Rodriguez, Davis Y. Torrejon, Wei Liu, Jesse M. Zaretsky, Theodore S. Nowicki, Jennifer Tsoi, Cristina Puig-Saus, Ignacio Baselga-Carretero, Egmidio Medina, Michael J. Quist, Alejandro J. Garcia, William Senapedis, Erkan Baloglu, Anusha Kalbasi, Gardenia Cheung-Lau, Beata Berent-Maoz, Begoña Comin-Anduix, Siwen Hu-Lieskovan, Cun-Yu Wang, Catherine S. Grasso, Antoni Ribas
October 9, 2026

1